This site is intended for healthcare professionals only
LoginRegister
AbbVie submits new drug application to USFDA for Tavapadon for Parkinsons diseaseAbbVie submits new drug application to USFDA for Tavapadon for Parkinsons disease
Patna Shocker: Pharma Representative Brutally Murdered, Probe UnderwayPatna Shocker: Pharma Representative Brutally Murdered, Probe Underway
Delhi ITAT Deletes Rs 14.98 Cr Ad-Hoc Disallowance on Mankind Pharmas Travel ExpensesDelhi ITAT Deletes Rs 14.98 Cr Ad-Hoc Disallowance on Mankind Pharma's Travel Expenses
Delhi Govt Bans Genetic Sample Transfers, Tightens Abortion Pill Sales to Curb Sex-Selective PracticesDelhi Govt Bans Genetic Sample Transfers, Tightens Abortion Pill Sales to Curb Sex-Selective...
CDSCO Panel Recommends Updating Prescribing Information for Sanofis VaccineCDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine
Eli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic Alzheimers diseaseEli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic...
Trademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HCTrademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HC
No Entry Without Notice: CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATEHimachal Drug Makers Unfazed by US 100% Tariff on Branded Drugs
Gujarat Medical, Dental Admissions Paused Amid AIQ Delays.PCI Bars 89 Pharmacy Colleges in Maharashtra from 2025-26 Admissions Over Regulatory Lapses
Indias generic drugs safe as Trump targets branded pharma imports: ExpertsIndia's generic drugs safe as Trump targets branded pharma imports: Experts
Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized InjectionsCDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in...
Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technologyPatent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology
X